UNSPSC 51271603: Bupivacaine

This classification denotes an anesthetic agent with the molecular formula C18H28N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y8335394RO, chemically known as 2-piperidinecarboxamide, 1-butyl-n-(2,6-dimethylphenyl)- but generally known as bupivacaine, which bears US NIH Compound Identifier 2474. Bupivacaine most often comes in base and hydrochloride forms. European Medicines Agency schedules Bupivacaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05983MIG.

UNSPSC 51271603 Bupivacaine, a Commodity code, covers the procurement of bupivacaine, a local anesthetic used in medical, dental, and surgical applications by state and local health systems, correctional facilities, and emergency services. State and local governments purchase bupivacaine in various formulations and concentrations for use in operating rooms, emergency departments, dental clinics, pain-management programs, and field medical operations. The code encompasses both single-dose vials and multi-dose containers supplied through pharmaceutical distributors or direct manufacturer agreements.

The source provides no recent state or local contract opportunities solicited under this code. Without posted RFPs, RFQs, ITBs, or IFBs naming bupivacaine procurement, the current market activity and geographic distribution cannot be characterized from available data.